issued
on 19 Nov 2024
Last Applicant/ Owned by
1189 LANCASTER AVE.
BERWYN
PA
19312
Serial Number
97652273 filed on 28th Oct 2022
Registration Number
N/A
Correspondent Address
Brittany L. Kulwicki
Brittany L. Kulwicki Calfee, Halter & Griswold LLP
The Calfee Building
Cleveland, OH 44114
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Software as a service (SAAS) services featuring software for initiating payments to be made via many methods of electronic fundstransfers utilizing a centralized virtual account in connection with clinical trials; Software as a service (SAAS) services featuringsoftware for workflow automation in support of payment processing activities in connection with clinical trials; software as aservice (SAAS Read More
Software as a service (SAAS) services featuring software for initiating payments to be made via many methods of electronic fundstransfers utilizing a centralized virtual account in connection with clinical trials; Software as a service (SAAS) services featuringsoftware for workflow automation in support of payment processing activities in connection with clinical trials; software as aservice (SAAS) solutions featuring non-downloadable software for the collection, interpretation, tracking and viewing of cost datain the field of clinical trials; software as a service (SAAS) solutions featuring non-downloadable software for use in managing dataand information in the field of medical clinical trials; software as a service (SAAS) solutions featuring non-downloadable softwarefor monitoring an account balance for a virtual account; Providing an online, non-downloadable software platform for paymenttransaction processing services
N/A
N/A
Travel services offered exclusively in the field of clinical trial travel, namely, coordinating rides for participants and their families to and from their appointments at a designated clinical research facility
N/A
N/A
prepaid purchase services, namely, processing of payments made via a virtual account allowing users to transfer value via anelectronic or optical communications network; Payment processing services, namely, administration and reconciliation oftransactions involving funds drawn from bank accounts on behalf of others using a variety of methods for transferring fundselectronically over a global computer network
N/A
N/A
Providing an online computer database featuring business information in the field of clinical trials; business research andconsulting based on information from monitoring clinical trials of pharmaceutical drugs for business purposes; administration andreconciliation of transactions involving funds drawn from bank accounts on behalf of others using a variety of methods fortransferring funds electronically over an electronic and optical communications network; conducting patient surveys for purposesof improving clinical trial payments
N/A
N/A
Downloadable computer software for monitoring a virtual account balance; Downloadable computer software for managingpayment workflows, payment requests, approval of payment requests, and payment reconciliation and detailed financial reportingfor clinical trials; Downloadable computer software for electronic collection, storage, distribution and analysis of payments;Downloadable computer software that provides web-based access to applications and services through a web operating system,or mobile application interface
N/A
N/A
Providing internet chat rooms
N/A
N/A
No 97652273
No Service Mark
No 41849.04001
No
No
No
No
No
No
No
No
19.13.02 -
Test tubes
Status Date | Action Taken |
---|---|
19th Nov 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
24th Sep 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
24th Sep 2024 | PUBLISHED FOR OPPOSITION |
04th Sep 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
16th Aug 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
02th Aug 2024 | ASSIGNED TO LIE |
02th Aug 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
02th Aug 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
21st Feb 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
16th Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |